相关实验视频
Updated: Jun 12, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
一种药物组合和剂量决定算法,用于个性化2型糖尿病管理
Mila Nambiar1, Yong Mong Bee2,3, Yu En Chan1
1Institute for Infocomm Research, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
NPJ digital medicine
|September 17, 2024
概括
一个由人工智能驱动的工具,AIDA,通过推最小的药物和剂量调整来优化2型糖尿病 (T2D) 药物治疗. 与标准护理相比,这种AI临床决策支持改善了血糖控制 (HbA1c).
科学领域:
- 人工智能在医学中的应用
- 计算健康 计算健康
- 糖尿病管理 糖尿病管理
背景情况:
- 目前的2型糖尿病 (T2D) 药物治疗指南促进以患者为中心的护理,但在门诊环境中面临实际挑战.
- 现有的数据驱动的治疗优化方法缺乏考虑药物特定和剂量依赖的安全性和疗效差异的能力.
研究的目的:
- 开发和评估AI药物混合和剂量顾问 (AIDA) 以优化T2D患者的血糖管理.
- 评估AIDA识别最小药物组合和剂量变化的能力,以改善血糖控制,同时遵守临床指南.
主要方法:
- 艾达是使用107,854名T2D患者的电子病历来开发的.
- 采用预测然后优化方法,将患者个人资料与基于临床知识的指导方针整合起来.
- 在内部,外部和时间数据集上验证了性能,由内分泌学家进行了定性评估.
主要成果:
- 据估计,AIDA的建议比标准护理 (P < 0.0001) 提高了0.40-0.68%的糖化血红蛋白 (HbA1c).
- 内分泌学家认为AIDA的建议在定性评估中大多是合理的和准确的.
- 艾达在与实践偏好一致,遵循指南并考虑脏剂量方面表现出优势.
结论:
- 艾达提供一个数据驱动的方法来个性化T2D药物治疗,解决当前方法的局限性.
- 人工智能工具可以提供关键的药物剂量建议,以改善患者的治疗结果.
- 艾达具有作为临床决策支持系统的潜力,特别是在资源有限的环境中.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
156
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
156
Diabetes: Management and Pharmacotherapy
244
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
244
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Oral Hypoglycemic Agents: Biguanides and Glitazones
182
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
182
Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K

